ZimVie (NASDAQ:ZIMV) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of ZimVie (NASDAQ:ZIMV - Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday morning.

A number of other equities research analysts also recently commented on ZIMV. B. Riley began coverage on shares of ZimVie in a research report on Thursday, April 10th. They issued a "buy" rating and a $16.00 price objective for the company. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th. Finally, UBS Group reduced their price target on shares of ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a research report on Thursday, May 15th.

ZimVie Stock Performance

Shares of ZIMV traded up $0.09 during mid-day trading on Friday, hitting $9.35. 159,460 shares of the company's stock were exchanged, compared to its average volume of 193,601. ZimVie has a fifty-two week low of $8.15 and a fifty-two week high of $22.40. The firm has a market capitalization of $260.40 million, a P/E ratio of 11.72 and a beta of 2.10. The business's 50 day moving average is $8.99 and its two-hundred day moving average is $11.36. The company has a current ratio of 2.14, a quick ratio of 1.48 and a debt-to-equity ratio of 0.58.

ZimVie (NASDAQ:ZIMV - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.06. The firm had revenue of $112.00 million during the quarter, compared to the consensus estimate of $113.10 million. ZimVie had a negative net margin of 4.40% and a positive return on equity of 5.53%. On average, equities analysts expect that ZimVie will post 0.6 earnings per share for the current year.

Institutional Investors Weigh In On ZimVie

Hedge funds and other institutional investors have recently modified their holdings of the stock. AlphaQuest LLC increased its stake in shares of ZimVie by 2,695.9% during the 1st quarter. AlphaQuest LLC now owns 8,947 shares of the company's stock worth $97,000 after purchasing an additional 8,627 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of ZimVie during the 1st quarter worth approximately $98,000. Jones Financial Companies Lllp increased its stake in shares of ZimVie by 9,039.1% during the 1st quarter. Jones Financial Companies Lllp now owns 12,612 shares of the company's stock worth $136,000 after purchasing an additional 12,474 shares in the last quarter. Hsbc Holdings PLC purchased a new position in shares of ZimVie during the 1st quarter worth approximately $144,000. Finally, State of Wyoming increased its stake in shares of ZimVie by 132.2% during the 1st quarter. State of Wyoming now owns 16,318 shares of the company's stock worth $176,000 after purchasing an additional 9,291 shares in the last quarter. 95.63% of the stock is currently owned by institutional investors and hedge funds.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.